Quick answers
- What is Doptelet?
- Doptelet is a brand name of Avatrombopag maleate, a prescription medicine. The FDA NDC Directory lists 1 Doptelet product in 1 strength and form.
- Who makes Doptelet?
- Akarx Inc holds the FDA application for Doptelet (NDA210238, approved May 21, 2018).
- Is there a generic or store brand of Doptelet?
- Other products of Avatrombopag maleate are listed with the FDA, but none in exactly the same strength and form as a Doptelet product.
- Has Doptelet been recalled?
- No recall linked to Doptelet products (by their NDC code or label) appears in the FDA enforcement reports we use.
What Doptelet is
Each Doptelet product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Avatrombopag maleate · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| avatrombopag maleate 20 mg tablet, film coated (oral) | Doptelet | None listed | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Avatrombopag maleate →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
Companies that list Doptelet
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Doptelet products.
- AkaRx, Inc.1 product
Recalls
No recall linked to Doptelet products (by their NDC code or label) appears in the FDA enforcement reports.
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.